Tenax Therapeutics, Inc. (TENX) is a publicly traded Healthcare sector company. As of November 5, 2026, TENX trades at $1.81 with a market cap of $68.86M and a P/E ratio of -1.44. TENX moved +0.00% today. Year to date, TENX is -85.36%; over the trailing twelve months it is -74.28%. Its 52-week range spans $1.31 to $19.40. Analyst consensus is buy with an average price target of $9.63. Rallies surfaces TENX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for TENX, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $1.81 |
| Market Cap | $68.86M |
| P/E Ratio | -1.44 |
| EPS | $-1.34 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.40 |
| 52-Week Low | $1.31 |
| Volume | 2.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-52.60M |
| Gross Margin | 0.00% |
10 analysts cover TENX: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $9.63.